483 Acella Pharmaceuticals Oct 2013

483 Acella Pharmaceuticals Oct 2013

Jawaid Hamid FDA$119.00 - Available Now

FDA investigators audited the Acella Pharmaceuticals - Alpharetta, GA, United States facility and issued 8 inspectional observations (via FDA 483) on 31 Oct 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 8
  • Inspection end: 31 Oct 2013
  • Location: Alpharetta, United States
  • FEI: 3006691461
Add To Cart